Compare Prostate Cancer Treatments – Intermediate Risk
Intermediate Risk patients experience a wider range of results and approaches due to the risk of disease beyond the prostate. When selecting a course of action, consultations are recommended with a urologist or surgeon, radiation oncologist and medical oncologist. Different treatments have different results and side effects. It is important to understand the potential impact each treatment can have on your quality of life after treatment.
Intermediate Risk is any of the following:
PSA greater than 10 less than 20
Gleason Score is 7
Clinical Stage is T2b
How to Use the Graph
Add or remove treatment options above, using the checkboxes, for example Surgery vs Seeds. Percent PSA Progression Free is represented by the the vertical axis. The bottom axis of the graph tracking time in years, in this case up to 16 years. Circles, triangles, diamonds or squares on the graph each represent a treatment study with a different number of patients. The midpoint of the ellipse shows on average how the patients responded to a that treatment. The direction of the ellipse, shows how the patients trended over time.
About the Data
Percent PSA Progression Free control results are the most sensitive means to measure initial treatment success and are used in these comparisons. A PSA Progression Free of 100% would mean that for all patients, the cancer has not returned, and no follow up treatment was necessary. These graphs are cancer control probabilities and not survival graphs. Survival in all groups is high regardless of treatment, as patients can often live for years despite failure of the initial treatment. Cancer control is the focus of this analysis. The longer a treatment can maintain a PSA Progression Free close to 100%, the more effective the Treatment. Each treatment ellipse is mathematically calculated to help you visualize how the patients are doing with the selected treatment.
For More Information:
Compare Prostate Cancer Treatment Tutorial
This tutorial will lead you through the process of comparing the outcomes for prostate cancer treatments, for low, intermediate and high risk patients.
Use this Data to Talk to Your Doctor About Your OptionsThe Prostate Cancer Results Study Group Full Report is an excellent resource to use during patient-doctor discussions. The report is available from the Foundation for a suggested $25 donation. Download
Help other men make better treatment decisions.
A $25 donation today helps us continue the groundbreaking working of the Prostate Cancer Treatment Study Group.